Suppr超能文献

缺血性应激暴露诱导的机械性痛觉过敏早期阶段中 DDAH1 对脊髓 NOS 信号的激活作用。

The Involvement of DDAH1 in the Activation of Spinal NOS Signaling in Early Stage of Mechanical Allodynia Induced by Exposure to Ischemic Stress in Mice.

机构信息

Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Kobe Gakuin University.

出版信息

Biol Pharm Bull. 2019;42(9):1569-1574. doi: 10.1248/bpb.b19-00371.

Abstract

The pathophysiological mechanism of central post-stroke pain (CPSP) is complicated and not well understood. Recently, it has been reported that an increase in the levels of spinal nitric oxide synthetase (NOS) occurs in cerebral ischemia, and spinal NOS is involved in the development of neuropathic pain. The aim of this study was to elucidate the mechanism of spinal NOS signaling in the development of CPSP. Male ddY mice were subjected to 30-min long bilateral carotid artery occlusion (BCAO). The withdrawal responses to mechanical stimuli were significantly increased as determined with von Frey test on days 1 and 3 after BCAO. Protein expression of spinal N,N-dimethylarginine dimethylaminohydralase 1 (DDAH1), a key enzyme involved in the metabolism of the endogenous NOS, increased on day 1 after BCAO, but not on day 3. Intrathecal (i.t.) injection of PD404182, a DDAH1 inhibitor, significantly suppressed mechanical allodynia on day 1, but not on day 3 after BCAO. In addition, i.t. administration of N-nitro-L-arginine methyl ester (L-NAME), a non-selective NOS inhibitor, significantly blocked mechanical allodynia on days 1 and 3 after BCAO. Furthermore, BCAO-induced increment of spinal NOS activity was inhibited by the pretreatment with PD404182. These results suggest that mechanical allodynia in the early stage of CPSP is caused by increment of NOS activity through upregulated DDAH1 in the spinal cord.

摘要

中枢性卒中后疼痛(CPSP)的病理生理机制复杂,尚未完全阐明。最近有报道称,脑缺血时脊髓一氧化氮合酶(NOS)水平升高,而脊髓 NOS 参与了神经性疼痛的发生。本研究旨在阐明脊髓 NOS 信号在 CPSP 发展中的机制。雄性 ddY 小鼠接受 30 分钟的双侧颈总动脉闭塞(BCAO)。von Frey 试验显示,BCAO 后第 1 天和第 3 天,机械刺激的退缩反应明显增加。参与内源性 NOS 代谢的关键酶脊髓 N,N-二甲基精氨酸二甲氨基水解酶 1(DDAH1)的蛋白表达在 BCAO 后第 1 天增加,但在第 3 天没有增加。鞘内(i.t.)注射 DDAH1 抑制剂 PD404182 可显著抑制 BCAO 后第 1 天的机械性痛觉过敏,但对第 3 天无影响。此外,鞘内给予非选择性 NOS 抑制剂 N-硝基-L-精氨酸甲酯(L-NAME)可显著阻断 BCAO 后第 1 天和第 3 天的机械性痛觉过敏。此外,PD404182 预处理可抑制 BCAO 诱导的脊髓 NOS 活性增加。这些结果表明,CPSP 早期的机械性痛觉过敏是由于脊髓中 DDAH1 上调导致 NOS 活性增加引起的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验